300 related articles for article (PubMed ID: 32504783)
1. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
Ahmad MF
J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
[TBL] [Abstract][Full Text] [Related]
2. Use of
González A; Atienza V; Montoro A; Soriano JM
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325828
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum: Multifaceted mechanisms to combat diabetes through polysaccharides and triterpenoids: A comprehensive review.
Ahmad MF; Ahmad FA; Hasan N; Alsayegh AA; Hakami O; Bantun F; Tasneem S; Alamier WM; Babalghith AO; Aldairi AF; Kambal N; Elbendary EY
Int J Biol Macromol; 2024 May; 268(Pt 1):131644. PubMed ID: 38642691
[TBL] [Abstract][Full Text] [Related]
4. Ganoderma lucidum (Reishi mushroom) for cancer treatment.
Jin X; Ruiz Beguerie J; Sze DM; Chan GC
Cochrane Database Syst Rev; 2012 Jun; (6):CD007731. PubMed ID: 22696372
[TBL] [Abstract][Full Text] [Related]
5. Ganoderma lucidum (Reishi) in cancer treatment.
Sliva D
Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review).
Cizmarikova M
Int J Med Mushrooms; 2017; 19(10):861-877. PubMed ID: 29256841
[TBL] [Abstract][Full Text] [Related]
7. Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.
Sohretoglu D; Huang S
Anticancer Agents Med Chem; 2018; 18(5):667-674. PubMed ID: 29141563
[TBL] [Abstract][Full Text] [Related]
8. Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties.
Ahmad MF; Ahmad FA; Khan MI; Alsayegh AA; Wahab S; Alam MI; Ahmed F
Int J Biol Macromol; 2021 Sep; 187():769-779. PubMed ID: 34197853
[TBL] [Abstract][Full Text] [Related]
9. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
Hsieh TC; Wu JM
Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
[TBL] [Abstract][Full Text] [Related]
10. Ganoderma lucidum and its pharmaceutically active compounds.
Boh B; Berovic M; Zhang J; Zhi-Bin L
Biotechnol Annu Rev; 2007; 13():265-301. PubMed ID: 17875480
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic triterpenoids from Ganoderma lucidum.
Cheng CR; Yue QX; Wu ZY; Song XY; Tao SJ; Wu XH; Xu PP; Liu X; Guan SH; Guo DA
Phytochemistry; 2010 Sep; 71(13):1579-85. PubMed ID: 20615519
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
[TBL] [Abstract][Full Text] [Related]
13. DNA damaging potential of Ganoderma lucidum extracts.
Gurovic MSV; Viceconte FR; Pereyra MT; Bidegain MA; Cubitto MA
J Ethnopharmacol; 2018 May; 217():83-88. PubMed ID: 29421594
[TBL] [Abstract][Full Text] [Related]
14.
Ahmad MF; Ahmad FA; Zeyaullah M; Alsayegh AA; Mahmood SE; AlShahrani AM; Khan MS; Shama E; Hamouda A; Elbendary EY; Attia KAHA
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111092
[No Abstract] [Full Text] [Related]
15. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement.
Ahmad MF
Biomed Pharmacother; 2018 Nov; 107():507-519. PubMed ID: 30114634
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
Sliva D; Labarrere C; Slivova V; Sedlak M; Lloyd FP; Ho NW
Biochem Biophys Res Commun; 2002 Nov; 298(4):603-12. PubMed ID: 12408995
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate.
Cilerdžić J; Vukojević J; Stajić M; Stanojković T; Glamočlija J
J Ethnopharmacol; 2014 Aug; 155(1):312-9. PubMed ID: 24879959
[TBL] [Abstract][Full Text] [Related]
19. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
Liang C; Tian D; Liu Y; Li H; Zhu J; Li M; Xin M; Xia J
Eur J Med Chem; 2019 Jul; 174():130-141. PubMed ID: 31035236
[TBL] [Abstract][Full Text] [Related]
20. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
Xu Z; Chen X; Zhong Z; Chen L; Wang Y
Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]